Skip to main content
. 2020 Feb 24;22(4):616–622. doi: 10.1111/jch.13832

Table 1.

Demographic and laboratory features of the groups

 

Group 1

(n = 51)

Group 2

(n = 53)

P
Age (y) 45.6 ± 12.3 49.6 ± 11.6 .10
Gender (F) 17 33 .003
Systolic blood pressure (mm Hg) 138.6 ± 14.2 146.6 ± 12.1 .003
Diastolic blood pressure (mm Hg) 81.8 ± 10.9 86.8 ± 8.6 .01
Heart rate (beat/min) 84.5 ± 8.8 84.3 ± 8.9 .88
Diabetes mellitus (n) 8 9 .85
Family history of CAD (n) 24 19 .25
Smoking (n) 13 25 .02
Glucose (mg/dL) 101.9 ± 27.8 110.3 ± 33.6 .18
Total cholesterol (mg/dL) 196.9 ± 75.2 217.4 ± 50.0 .15
Triglyceride (mg/dL) 190.9 ± 103.6 166.4 ± 131.4 .35
LDL cholesterol (mg/dL) 131.1 ± 35.0 140.0 ± 42.9 .30
HDL cholesterol (mg/dL) 43.7 ± 11.2 44.6 ± 10.1 .71
Urea (mg/dL) 29.0 ± 8.8 29.2 ± 7.8 .90
Creatinine (mg/dL) 0.82 ± 0.45 0.73 ± 0.13 .16
Sodium (mEq/L) 139.9 ± 2.2 140.1 ± 2.2 .62
Potassium (mEq/L) 4.40 ± 0.33 4.41 ± 0.34 .85
AST (mg/dL) 24.2 ± 11.7 22.3 ± 9.7 .39
ALT (mg/dL) 29.0 ± 20.7 24.1 ± 11.2 .15

Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; CAD, coronary artery disease; F, female; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.

The significance of bold values are p  < .01, p  < .05.